Nextage Therapeutics Ltd
Tel Aviv Stock Exchange NXTG.TA
Nextage Therapeutics Ltd EPS (Diluted) for the year ending December 31, 2023: USD -0.04
Nextage Therapeutics Ltd EPS (Diluted) is USD -0.04 for the year ending December 31, 2023. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.
-
Nextage Therapeutics Ltd EPS (Diluted) for the year ending December 31, 2021 was USD -0.10, a 77.83% change year over year.
-
Nextage Therapeutics Ltd EPS (Diluted) for the year ending December 31, 2020 was USD -0.44, a -31.00% change year over year.
-
Nextage Therapeutics Ltd EPS (Diluted) for the year ending December 31, 2019 was USD -0.33, a 81.91% change year over year.
Key data
| Date | EPS (Diluted) | Shares (Diluted, Weighted) | Shares (Basic, Weighted) | Revenue |
|---|
Market news
Loading...
Tel Aviv Stock Exchange: NXTG.TA
| CEO | Mr. Abraham Dreazen |
| IPO Date | Aug. 12, 2002 |
| Location | Israel |
| Headquarters | Einstein St. Building 13B |
| Employees | 42 |
| Sector | Health Care |
| Industries | |
Description
Nextage Therapeutics Ltd develops cannabinoid-based products. The company is based in Ness Ziona, Israel.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email